These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of chemotherapy combined with caffeine for osteosarcoma. Tsuchiya H, Yasutake H, Yokogawa A, Baba H, Ueda Y, Tomita K. J Cancer Res Clin Oncol; 1992; 118(8):567-9. PubMed ID: 1517277 [Abstract] [Full Text] [Related]
23. [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients]. Wang QL, Sun Y, Zhou JC, Song SZ, Feng FY, Lu L, Yie ZS. Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):152-4. PubMed ID: 3264785 [Abstract] [Full Text] [Related]
26. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. Ferrari S, Ruggieri P, Cefalo G, Tamburini A, Capanna R, Fagioli F, Comandone A, Bertulli R, Bisogno G, Palmerini E, Alberghini M, Parafioriti A, Linari A, Picci P, Bacci G. J Clin Oncol; 2012 Jun 10; 30(17):2112-8. PubMed ID: 22564997 [Abstract] [Full Text] [Related]
28. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C. Cancer; 1993 Dec 01; 72(11):3227-38. PubMed ID: 8242546 [Abstract] [Full Text] [Related]
30. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases. Marroum MC, Huvos AG, Rosen G. Oncology; 1977 Dec 01; 34(6):273-80. PubMed ID: 304199 [Abstract] [Full Text] [Related]
31. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss). Ferrari S, Meazza C, Palmerini E, Tamburini A, Fagioli F, Cozza R, Ferraresi V, Bisogno G, Mascarin M, Cefalo G, Manfrini M, Capanna R, Biagini R, Donati D, Picci P. Tumori; 2014 Dec 01; 100(6):612-9. PubMed ID: 25688494 [Abstract] [Full Text] [Related]
35. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results. Bacci G, Picci P, Ferrari S, Sangiorgi L, Mercuri M, Bertoni F, Brach del Prever A, Tienghi A, Mancini A, Comandone A. Chir Organi Mov; 1995 Dec 01; 80(1):1-10. PubMed ID: 7641534 [Abstract] [Full Text] [Related]
36. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Cancer; 1979 Jun 01; 43(6):2163-77. PubMed ID: 88251 [Abstract] [Full Text] [Related]
38. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F. Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175 [Abstract] [Full Text] [Related]
40. Hyperthermic isolated perfusion using cisplatin for treatment of the extremities. Takeyama S, Tateishi A, Higaki S, Yamanashi M. Cancer Treat Res; 1993 Nov 15; 62():235-40. PubMed ID: 8096738 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]